Maynard Um
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Tops Q4 EPS by 6c, Offers Guidance
-
-
-
-
-
-
-
Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Tops Q1 EPS by 3c ; Offers Guidance
-
-
-
-
-
-
-
Myriad Genetics (MYGN) PT Lowered to $11 at Jefferies
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance
-
-
-
-
-
-
-
TD Cowen Reiterates Hold Rating on Myriad Genetics (MYGN)
-
-
-
-
-
-
-
JPMorgan Reiterates Underweight Rating on Myriad Genetics (MYGN)
-
406,727 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

